Current Status of Histologic Grading in Prostate Carcinoma and Renal Cell Carcinoma | Zendy

Duygu Kankaya | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Status of Histologic Grading in Prostate Carcinoma and Renal Cell Carcinoma

Author(s) -

Duygu Kankaya

Publication year - 2017

Publication title -

journal of urological surgery

Language(s) - English

Resource type - Journals

ISSN - 2148-9580

DOI - 10.4274/jus.1513

Subject(s) - medicine , grading (engineering) , renal cell carcinoma , prostate carcinoma , oncology , carcinoma , prostate , pathology , cancer , civil engineering , engineering

Tumor grading is a fundamental component of histopathologic examination which is expected to provide prognostic information in addition to tumor stage and even contribute to making decision about the type of treatment. Gleason and Fuhrman gradings are widely used grading systems for prostate carcinoma and renal cell carcinoma (RCC), respectively (1,2). Despite of their widespread use, the purpose of increasing their prognostic significance has given rise to modifications several times. The International Society of Urological Pathology (ISUP) arranged consensus conferences in 2012 for RCC, and in 2014 for prostate carcinoma, in an attempt to enhance the efficiency of both these grading systems (3,4).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research